[
1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–20.10.1056/NEJMoa2002032
]Search in Google Scholar
[
2. Phelan AL, Katz R, Gostin LO. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA. 2020; 323(8): 709–10.10.1001/jama.2020.1097
]Search in Google Scholar
[
3. World Health Organization. Main website. 2020. Available at: https://www.who.int. Accessed March 2, 2020.
]Search in Google Scholar
[
4. Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016; 92(3): 235–50.10.1016/j.jhin.2015.08.027
]Search in Google Scholar
[
5. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015; 386(9997): 995–1007.10.1016/S0140-6736(15)60454-8
]Search in Google Scholar
[
6. Wang H, Li X, Li T, Zhang S, Wang L, Wu X, et al. The genetic sequence, origin, and diagnosis of SARS-CoV- 2. Eur J Clin Microbiol Infect Dis. 2020; 39(9): 1629–35.10.1007/s10096-020-03899-4
]Search in Google Scholar
[
7. Zheng J. SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat. Int J Biol Sci. 2020; 16(10): 1678–85.10.7150/ijbs.45053
]Search in Google Scholar
[
8. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int J Antimicrob Agents. 2020; 55(5): 105951.10.1016/j.ijantimicag.2020.105951
]Search in Google Scholar
[
9. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. N Engl J Med. 2020; 382(13): 1199–207.10.1056/NEJMoa2001316
]Search in Google Scholar
[
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5): 373–83.10.1016/0021-9681(87)90171-8
]Search in Google Scholar
[
11. Institute of Public Health of Serbia “Dr Milan Jovanović Batut.” Expert-Methodological Instruction for Control of Introduction and Prevention of Spread of SARS-CoV- 2 Coronavirus in the Republic of Serbia. Belgrade. 2020.
]Search in Google Scholar
[
12. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. 2020. Available at: https://www.who.int/publications-detail-redirect/10665-331501. Accessed July 7, 2020.
]Search in Google Scholar
[
13. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019; 200(7): e45–67.10.1164/rccm.201908-1581ST681243731573350
]Search in Google Scholar
[
14. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3): 128–40.10.1016/0196-6553(88)90053-3
]Search in Google Scholar
[
15. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223): 507–13.10.1016/S0140-6736(20)30211-7
]Search in Google Scholar
[
16. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020; 80(6): 607–13.10.1016/j.jinf.2020.03.037
]Search in Google Scholar
[
17. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81(2): e16–25.10.1016/j.jinf.2020.04.021
]Search in Google Scholar
[
18. Castrucci MR. Factors affecting immune responses to the influenza vaccine. Hum Vaccines Immunother. 2017; 14(3): 637–46.10.1080/21645515.2017.1338547
]Search in Google Scholar
[
19. Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. Am J Respir Crit Care Med. 2020; 201(11): 1372–9.10.1164/rccm.202003-0543OC
]Search in Google Scholar
[
20. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061–9.10.1001/jama.2020.1585
]Search in Google Scholar
[
21. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–62.10.1016/S0140-6736(20)30566-3
]Search in Google Scholar
[
22. Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020; 92(10): 1875–83.10.1002/jmv.26050728066632441789
]Search in Google Scholar
[
23. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20): 2052–9.10.1001/jama.2020.6775717762932320003
]Search in Google Scholar
[
24. Myers LC, Parodi SM, Escobar GJ, Liu VX. Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. JAMA. 2020; 323(21): 2195–8.10.1001/jama.2020.7202718296132329797
]Search in Google Scholar
[
25. Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. J Med Virol. 2020; 92(6): 612–7.10.1002/jmv.25735722825532108351
]Search in Google Scholar
[
26. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med. 2020; 382(21): 2012–22.10.1056/NEJMoa2004500714316432227758
]Search in Google Scholar